Notably, fimepinostat, a dual inhibitor of HDAC and PI3K, was recently shown in leukemia cell lines to reduce the levels of additional proteins with critical roles in DNA replication, including RRM2, CHK1, and WEE1 (57, 58). This evidence concerns the gene HDAC9 and leukemia.